WALTHAM, Mass. – NeuroMetrix announced Wednesday that Quell was named Winner in a Wearable Tech difficulty during a 19th Annual SXSW Interactive Innovation Awards, hold in Austin, Texas.
The Wearable Tech endowment honors “new hardware that revolutionizes a convenience, comfort, functionality, potency and conform of carrying a device literally ‘on you.’” Quell was famous for a breakthrough record by going over normal wearables that usually offer tracking, to truly improving a peculiarity of life for a users.
“We are gay that Quell was famous by a SXSW Interactive Innovation Awards,” settled Shai Gozani, boss and CEO of NeuroMetrix. “This endowment and other new honors given to Quell, underscore a groundbreaking record and a disproportion creation can make in a lives of a millions of people around a universe pang from ongoing pain.”
Designed to provide a far-reaching operation of ongoing pain conditions, Quell was launched in Jun 2015 and is already carrying a large impact on users. In a new clinical study, 81% of participants cited reduced pain with Quell and 67% reported a rebate in pain remedy use, after 60 days.
Worn usually next a knee, a law OptiTherapy record in Quell delivers customizable, 100% drug giveaway ongoing pain service to wearers, but a prescription. It is a usually over-the-counter ongoing pain wearable that has been FDA privileged for use while sleeping.
Let’s retard ads! (Why?)